8th Expanded Access Progammes World Congress 2025 Europe
Comprehensive Analysis on Executing Expanded Access Programmes
Wednesday 19th - Thursday 20th March 2025
Dr David Gillen
Chief Medical Officer
Katja Berg
Innovative Value and Access Strategy
ADAM JONES
Vice President International Medical
Sara Radenovic*
Director, Managed Access
SHEELA UPADHYAYA
Chair Elect, Rare Disease Special Interest Group
DAN LEWI
Head of Business Development and Patient Advocacy
Pulse infoframe Inc., Co- founder, CATS Foundation
DAN LEWI
Head of Business Development and Patient Advocacy
JENNIFER GRIGONIS
Sr. Director Business Development, EAP
Lindsay Randall
Founder, CEO, Mother
Dr. Alberto Calabrò
Patient Access Program and Supply Leader
Ana Tediosi
Head of Expanded Access Strategy
DR MICHELE AFIF
CEO
Pedro Franco
Sr Director, Head, Europe Global Regulatory & Scientific Policy
JULIE POWELL
Marketing & Communications Director
Carole Scrafton
Director & Co-Founder
JULIET HULSE
Head of Clinical Operations
DANIEL O’CONNOR
Director, Regulatory Policy and Early Access
Bob Stevens
Group CEO
DR POOJA TAKHAR
Joint Chief Executive Shortly
Senior Representative
Awaiting for Photo & Bio
Senior Representative
Awaiting for Photo & Bio